Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.1K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving Forward from "Fine Particle Fraction: The Good and the Bad".

Journal of aerosol medicine and pulmonary drug delivery·2022
Same author

In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation.

Advanced drug delivery reviews·2020
Same author

Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases.

Advanced drug delivery reviews·2018
Same author

Drug delivery to the lungs: challenges and opportunities.

Therapeutic delivery·2017
Same author

In vitro/in vivo comparisons in pulmonary drug delivery.

Journal of aerosol medicine and pulmonary drug delivery·2008
Same author

Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate.

International journal of pharmaceutics·2008

Related Experiment Video

Updated: Oct 3, 2025

A New Portable In Vitro Exposure Cassette for Aerosol Sampling
07:01

A New Portable In Vitro Exposure Cassette for Aerosol Sampling

Published on: February 22, 2019

7.3K

Fine Particle Fraction: The Good and the Bad.

Stephen P Newman1

  • 1Stephen P. Newman, 6 Nelson Drive, Hunstanton PE36 5DU, United Kingdon of Great Britain and Northern Ireland.

Journal of Aerosol Medicine and Pulmonary Drug Delivery
|February 16, 2022
PubMed
Summary

Fine particle fraction (FPF) measures aerosol quality for lung drug delivery. While useful, FPF alone doesn't fully predict lung deposition or clinical outcomes, necessitating further research.

Keywords:
Cascade impactorsclinical responselung depositionparticle sizepharmacokinetics

More Related Videos

A System to Create Stable Nanoparticle Aerosols from Nanopowders
12:59

A System to Create Stable Nanoparticle Aerosols from Nanopowders

Published on: July 26, 2016

9.7K
Composition and Distribution Analysis of Bioaerosols Under Different Environmental Conditions
05:45

Composition and Distribution Analysis of Bioaerosols Under Different Environmental Conditions

Published on: January 7, 2019

11.4K

Related Experiment Videos

Last Updated: Oct 3, 2025

A New Portable In Vitro Exposure Cassette for Aerosol Sampling
07:01

A New Portable In Vitro Exposure Cassette for Aerosol Sampling

Published on: February 22, 2019

7.3K
A System to Create Stable Nanoparticle Aerosols from Nanopowders
12:59

A System to Create Stable Nanoparticle Aerosols from Nanopowders

Published on: July 26, 2016

9.7K
Composition and Distribution Analysis of Bioaerosols Under Different Environmental Conditions
05:45

Composition and Distribution Analysis of Bioaerosols Under Different Environmental Conditions

Published on: January 7, 2019

11.4K

Area of Science:

  • Pharmaceutical Sciences
  • Inhalation Technology
  • Drug Delivery

Background:

  • Fine particle fraction (FPF) is crucial for inhaled medications, representing particles small enough to reach the lungs.
  • Current definitions of FPF lack universal agreement on aerodynamic diameter thresholds.
  • FPF alone is insufficient to characterize aerosol particle size distribution.

Purpose of the Study:

  • To critically evaluate the definition and utility of Fine Particle Fraction (FPF) in aerosol drug delivery.
  • To assess the relationship between FPF and *in vivo* drug deposition and clinical effects.
  • To identify limitations of current *in vitro* FPF measurements.

Main Methods:

  • Review of pharmacopeial methods for FPF determination using cascade impactors.
  • Analysis of the correlation between FPF and lung deposition.
  • Examination of the relationship between FPF and pharmacokinetic/clinical responses.

Main Results:

  • FPF is primarily a measure of aerosol quality, not a direct predictor of *in vivo* behavior.
  • Standard FPF measurements can overestimate lung deposition and may not accurately compare different inhaler types.
  • The link between FPF and pharmacokinetics/clinical outcomes remains poorly understood.

Conclusions:

  • FPF is a valuable but limited metric for inhaled drug aerosols.
  • Further research is needed to understand FPF's relationship with clinical efficacy.
  • Improving *in vitro* test methods, like realistic airway inlets and breathing patterns, may enhance predictive accuracy for *in vivo* drug delivery.